AI assistant
Sending…
Chorus Limited (NS) — Director's Dealing 2018
Sep 10, 2018
66180_rns_2018-09-10_2f05ae98-4ed8-4360-8329-2354198fb8e5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [103 x 28] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | Chorus Limited | |
| Date this disclosure made: | 10-Sep-18 | |
| Date of last disclosure: | 3-Aug-18 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Nick Woodward | |
| Name of listed issuer: | Chorus Limited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Former General Manager Product Sales and Marketing |
|
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class ofaffected quotedfinancialproducts: | ChorusLimited ordinary shares | |
| Nature of the affected relevant interest(s): | Beneficial holder pursurant to a custodial | |
| relationship with First New Zealand Capital | ||
| Securities Limited. | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 24,114 | |
| Number held in class after acquisition or disposal: | 0 | |
| Current registered holder(s): | FNZ Custodians Limited | |
| Registeredholder(s) once transfers areregistered: | Unknown | |
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: | ||
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 1 | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 6-Sep-18 | |
| Nature of transaction: | On market divestment of Chorus Limited | |
| ordinary shares. | ||
| Name ofany otherparty orparties to the transaction(if known): | Unknown | |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition | ||
| or disposal. If the consideration was not in cash and cannot be readily by converted into a | ||
| cash value,describe the consideration: | $116,928.79 | |
| Number of financial products to which the transaction related: | 24,114 |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: |
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: |
|
|---|---|---|
| Whether relevant interests were acquired or disposed of during a closed period: | No | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | |
| Date of theprior written clearance (if any): | N/A | |
| Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- |
||
| N/A | ||
| N/A | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
N/A | |
| A statement as to whether the derivative is cash settled or physically settled: | ||
| Maturity date of the derivative (if any): | ||
| Expiry date of the derivative (if any): | ||
| The price's specified terms (if any): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
||
| For that derivative relevant interest,- | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
||
| Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorisedperson: |
||
| 10-Sep-18 | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | ||
| Name and title of authorisedperson: |
More from Chorus Limited (NS)
Report Publication Announcement
2026
May 28
Major Shareholding Notification
2026
May 12
Major Shareholding Notification
2026
May 11
Capital/Financing Update
2026
May 5
Interim / Quarterly Report
2026
Apr 14
Notice of Dividend Amount
2026
Mar 23
Director's Dealing
2026
Mar 1
Major Shareholding Notification
2026
Feb 25
Report Publication Announcement
2026
Feb 22
Regulatory Filings
2026
Jan 29